e12513#Background:The Breast Cancer Index (BCI) is a gene expression-based biomarker that reports two results: BCI Predictive [BCI (H/I)], which predicts benefit from extended endocrine therapy (EET), and BCI Prognostic, which combines the Molecular Grade Index (MGI) with BCI (H/I) to ...
Cite this article Breast Cancer Research and TreatmentAims and scopeSubmit manuscript 57Accesses Explore all metrics Rights and permissions Reprints and permissions About this article Cite this article Index.Breast Cancer Res Treat82(Suppl 1), 185–195 (2003). https://doi.org/10.1023/A:1026204409234...
The predictive value of positive test results in screen- ing for breast cancer by mammography in the Nijmegen pro- gramme. BrJ Cancer 1987;56:667-71.Peeters, PHM, Verbeek, ALM, Hendriks, JHCL (1987) The predictive value of positive test results in screening for breast cancer by mammography...
Fig. 4: The visualization results of t-SNE for the task of predicting 4-category molecular subtypes of breast cancer in the test cohort (n = 672). a–f Original test dataset, Multi-ResNet, MulR-interSA, MulR-iiSA, MulR-interCSA, and proposed MDL-IIA models. MulR Multi-ResNet...
Likelihood ratio (LR) statistics were used with the χ2 test and C indexes to assess the prognostic value of each signature. Results In this study of 774 postmenopausal women with ER-positive, ERBB2-negative disease (mean [SD] age, 64.1 [8.1] years), 591 (mean [SD] age, 63.4 [7.9]...
Results Among the 3460 women included in the analysis (mean [SD] age, 63.6 [7.6] years), multivariable-adjusted hazard ratios for the risk of invasive breast cancer were 1.89 (95% CI, 1.21-2.95) for the highest quartile of whole-body fat and 1.88 (95% CI, 1.18-2.98) for the highest...
Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, Pandya KJ, Page DL, Robert NJ: Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin ...
Results An assay to identify candidate genes for a Notch transcriptomic signature To identify a Notch transcriptional signature for breast cancer, we first set out to identify genes regulated by Notch signalling in a breast cancer context. To this end, we established an assay in which modulation ...
In reviewing the data for the 10th interim analyses on May 31, 2002, the DSMB found that the adverse effects in cardiovascular diseases persisted, although these results were still within the monitoring boundaries. However, the design-specified weighted log-rank test statistic for breast cancer (z...
Materials and methods: Retrospective study of patients undergoing Savi-seed deployment over the period of 5 months for non-palpable breast cancer. Results: Of the 23 patients undergoing therapeutic excision, all presented at the symptomatic clinic. Savi-seed was either deployed at the time of the ...